S8038 (2023-24 session)
NY State bill
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination which includes the clinical review criteria relied upon to make such determination and any applicable alternative prescription drugs subject to the step therapy protocol of the utilization review agent.
- Title
- Relates to adverse determinations related to a step therapy protocol override determination; repealer
- Type
- New York State Senate bill
- Session
- 2023-24 session
- Status
- Senate Floor Calendar
- Latest action date
- 2024-01-08
- Introduced
- 2024-01-05
- Same as
- A8501
- Substituted by
- A8501
- Law section
- Insurance Law
Sponsors
Heard in committee
- Rules NY State Senate committee
Same as
- A8501 (2023-24 session) NY State bill
Substituted by
- A8501 (2023-24 session) NY State bill
Committee meetings
Committee meetings that took this bill up, from the Senate's published agendas. The Assembly does not publish its committee agendas in machine-readable form, so an Assembly committee's consideration of a bill is not on this list.
- Rules, 2024-01-08 Third reading